Inactive Instrument

Press Releases Novadel Pharma Inc

Equities

NVDL

US66986X1063

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NovaDel Pharma Inc. : Announces Dissolution of the Company	17-02-22	BU
Novadel Pharma : Reports Resolution of Contingent Liabilities	16-02-04	BU
Novadel Pharma : Announces Update to Agreement with Amherst Pharmaceuticals	15-01-30	BU
Novadel Pharma : Announces the Sale of Its ZolpiMist® New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC	14-09-22	BU
Novadel Pharma : Announces Proposed Actions to Complete Liquidation of Assets and Cash Distribution to Shareholders	14-03-26	BU
Novadel Pharma Inc : NovaDel Announces the Sale of its NitroMist® New Drug Application, License and Intellectual Property to Mist Pharmaceuticals, LLC.	13-11-19	BU
Novadel Pharma Inc : NovaDel Announces Completion of the Sale of Substantially All Assets to Suda Ltd.	13-08-13	BU
Novadel Pharma Inc : NovaDel Announces Stockholder Approval of Sale of Substantially All Assets to Suda Ltd.	13-07-19	BU
Novadel Pharma Inc : NovaDel Announces Adjournment of Special Stockholder Meeting	13-06-27	BU
Novadel Pharma Inc : NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist? Technology and Certain Other Assets	13-04-08	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Twelve Months Ended December 31, 2012	13-03-27	BU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist(tm) Technology	12-12-26	PU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist? Technology	12-12-26	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Nine Months Ended September 30, 2012	12-11-15	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Six Months Ended June 30, 2012	12-07-31	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011	12-03-20	BU
Novadel Pharma Inc : NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product	12-01-20	BU
Novadel Pharma Inc : NovaDel Continuing to Explore Strategic Alternatives	12-01-18	BU
Novadel Pharma Inc : NovaDel Reports Financial Results for Third Quarter 2011	11-11-01	BU
NOVADEL PHAMA : NovaDel Pharma Inc. Recent Events	11-08-30	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Novadel Pharma Inc

Equities

NVDL

US66986X1063

Press Releases

Filters